Literature DB >> 526390

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.

J Bahlmann, J Brod, W Hubrich, M Cachovan, P Pretschner.   

Abstract

1 The effect of an intravenous bolus of labetalol (0.6--1.6 mg/kg body weight) on central and peripheral haemodynamics was studied in nine subjects with essential hypertension and in eleven subjects with chronic renal disease and hypertension. 2 The BP reduction amounting to 20/13 mmHg was entirely due to the lowering of the total peripheral vascular resistance. This also included the vascular resistance in the muscles. 3 This peripheral vasodilatation was not counteracted by a reflex increase of the cardiac output. 4 The reflex tachycardia and overshoot of BP in Valsalva's manoeuvre were largely abolished. 5 Central and peripheral venous BPs, vascular volume of the forearm and venous distensibility did not show any significant change after treatment with labetalol. 6 In spite of the lowering of the vascular resistance of the forearm by labetalol, forearm blood flow was not significantly affected due to the parallel decrease in the perfusion pressure. 7 Plasma renin activity fell after labetalol in all instances.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526390      PMCID: PMC1429739     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects.

Authors:  J BROD; V FENCL; Z HEJL; J JIRKA
Journal:  Clin Sci       Date:  1959-05       Impact factor: 6.124

2.  Haemodynamics of hypertension in chronic renal disease.

Authors:  J Brod; J Bahlemann; M Cachovan; H D Dahlgrün; H Hundeshagen; U Feldmann
Journal:  Contrib Nephrol       Date:  1977       Impact factor: 1.580

3.  [The capacity system in hypertension].

Authors:  J Brod; M Cachovan; D Harmjanz; H Hundeshagen; H U Pixberg; B Herbst
Journal:  Verh Dtsch Ges Inn Med       Date:  1974

4.  Effect of diazoxide on capacitance vessels.

Authors:  J Bahlmann; J Brod; M Cachovan
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

  4 in total
  5 in total

Review 1.  Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors:  W H Frishman
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

Review 2.  Comparison of labetalol with other anti-hypertensive drugs.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

3.  Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.

Authors:  G Koch
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Changes in rates of beta-blocker use in community hospital patients with acute myocardial infarction.

Authors:  Adesuwa B Olomu; Ralph E Watson; Azfar-e-Alam Siddiqi; Francesca C Dwamena; Barbara A McIntosh; Peter Vasilenko; Joel Kupersmith; Margaret M Holmes-Rovner
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

Review 5.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.